The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: Looking back and looking ahead

被引：4
作者：
Hayes, TA [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ 08543 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 06期
关键词：
D O I：
10.1016/S0009-9236(98)90083-2
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：607 / 616
页数：10
相关论文
共 42 条
[1]  
ADAMS DG, 1994, SETON HALL L REV, V24, P1399
[2]  
BOULDING MH, 1995, J PHARM L, V4, P131
[3]  
BRANNON M, 1991, ORG REORGANIZING FDA
[4]  
CHADDUCK HW, 1972, FDA PAPERS FEB
[5]  
CHESEMORE RG, 1994, COMMUNICATION 0708
[6]  
COOPER RM, 1995, FOOD DRUG LAW J, P117
[7]  
COOPER RM, 1995, FOOD DRUG LAW J
[8]  
COOPER RM, 1995, FOOD DRUG LAW J, P118
[9]  
CROUT RJ, 1997, 98 ANN ASCPT M SAN D
[10]  
*FDC, 1997, PINK SHEET, V59, P6
12345